EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Endocrine Alterations in Patients With Pachydermoperiostosis

Maria Stelmachowska-Banaś iD, Sayka Barry iD, Ishita Angurala, Tom Rice, Kesson Magid iD, Ana Carreira, Ashutosh Rai, Amy Evans, Mark Bollington, Vaishali Kaur, Shallu Singhmar, Cristina Alina Silaghi iD und 10 weitere

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Maria Stelmachowska-Banaś und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland. Hauptthemen laut MEDLINE: Osteoarthropathy, Primary Hypertrophic, Organic Anion Transporters, Hydroxyprostaglandin Dehydrogenases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Pachydermoperiostosis (primary hypertrophic osteoarthropathy, PHO), usually due to biallelic loss of function variants in HPGD and SLCO2A1, has some features overlapping with acromegaly and is often referred to endocrinologists. A detailed endocrine assessment is not available for these patients.

Objective

To assess the genetic and endocrine characteristics of patients with PHO referred to endocrine centers with a possible diagnosis of acromegaly.

Methods

Seventeen patients from 14 families in which acromegaly was excluded based on lack of elevated insulin-like growth factor (IGF)-1 levels and/or growth hormone suppression on an oral glucose tolerance test were assessed for HPGD and SLCO2A1 variants.

Results

Age at diagnosis was 26.2 ± 9.0 years (mean ± SD, range 9-43). Digital clubbing was present in all patients. Periostosis (94%), arthralgia (88%), periarticular edema (77%), pachydermia (82%), and coarsened facial features resembling acromegaly (71%) were present in the vast majority of the patients, while eyelash trichomegaly, blepharoptosis, high-arched palate, gingival hypertrophy, gastrointestinal symptoms, and marfanoid habitus were seen in some. Nine patients (53%) had low IGF-1 levels; the rest of the patients had IGF-1 levels in the lowest quartile of the reference range. Estradiol concentration was increased above the normal range in 8 male patients (62%) with normal testosterone and prolactin levels. Biallelic HPGD (2/14 kindreds) or SLCO2A1 (8 novel) variants (12/14 kindreds) were found. Two patients had no identifiable pathogenic/likely pathogenic variant in HPGD or SLCO2A1. Their phenotype was not different from the other patients.

Conclusion

We establish that low IGF-1 and elevated estradiol levels are frequent features of PHO. Nine novel and 5 known pathogenic/likely pathogenic genetic variants were identified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteoarthropathy, Primary HypertrophicOrganic Anion TransportersHydroxyprostaglandin DehydrogenasesHumansMaleFemaleAdultAdolescentYoung AdultChildAcromegalyInsulin-Like Growth Factor I

Stichwörter der Autor:innen

HPGDSLCO2A1pachydermoperiostosisprimary hypertrophic osteoarthropathypseudoacromegaly

Substanzen

SLCO2A1 protein, humanInsulin-Like Growth Factor IOrganic Anion TransportersHydroxyprostaglandin DehydrogenasesIGF1 protein, human

Autor:innen und Institutionen

  • Department of Endocrinology, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.
  • Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
  • Department of Endocrinology, Nehru Hospital Extension, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
  • Department of Endocrinology, Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca, 400012 Cluj-Napoca, Romania.
  • Department of Medicine, College of Health Sciences, Parirenyatwa Group of Hospitals Harare, University of Zimbabwe, 52RV+556 Harare, Zimbabwe.
  • Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry 605006, India.

ORCID-Profile: Maria Stelmachowska-Banaś, Sayka Barry, Kesson Magid, Cristina Alina Silaghi, Jayaprakash Sahoo, Ayan Roy, Pinaki Dutta, Márta Korbonits

Zitieren

APA

Stelmachowska-Banaś, M., Barry, S., Angurala, I., Rice, T., Magid, K., Carreira, A., Rai, A., Evans, A., Bollington, M., Kaur, V., Singhmar, S., Silaghi, C. A., Mandisodza, K., McGregor, A., Sahoo, J., Gupta, R., Behera, K. K., Roy, A., Carr, I. M., …, & Korbonits, M. (2025). Endocrine Alterations in Patients With Pachydermoperiostosis. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf050

Vancouver

Stelmachowska-Banaś M, Barry S, Angurala I, Rice T, Magid K, Carreira A, et al. Endocrine Alterations in Patients With Pachydermoperiostosis. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf050

BibTeX
@article{StelmachowskaBana2025,
  author = {Stelmachowska-Banaś, Maria and Barry, Sayka and Angurala, Ishita and Rice, Tom and Magid, Kesson and Carreira, Ana and Rai, Ashutosh and Evans, Amy and Bollington, Mark and Kaur, Vaishali and Singhmar, Shallu and Silaghi, Cristina Alina and Mandisodza, Kudakwashe and McGregor, Alan and Sahoo, Jayaprakash and Gupta, Rahul and Behera, Kishore Kumar and Roy, Ayan and Carr, Ian M and Loughrey, Paul Benjamin and Dutta, Pinaki and Korbonits, Márta},
  title = {Endocrine Alterations in Patients With Pachydermoperiostosis},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf050}
}
Kostenlos starten →